Jingyan Wei
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Redox biology and oxidative stress 12
- Extracellular vesicles in disease 5
- Glutathione Transferases and Polymorphisms 4
-
- Selenium in Biological Systems 17
- Co-authors
- Guangjun Nie (19 shared papers)Gregory J. Anderson (5 shared papers)Suping Li (10 shared papers)Tianjiao Ji (5 shared papers)Jian Song (1 shared paper)Yanhua Tian (1 shared paper)Motao Zhu (1 shared paper)Yuliang Zhao (3 shared papers)
- Journals
- IUBMB Life (3 papers)Free Radical Biology and Medicine (2 papers)Nano Letters (2 papers)Biomaterials (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jingyan Wei
54 papers receiving 3.8k citations
Jingyan Wei's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 1.0k
- Biomaterials 506
- Molecular Biology 2.5k
- Biomedical Engineering 1.3k
- Immunology 288
Countries citing papers authored by Jingyan Wei
This map shows the geographic impact of Jingyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Wei more than expected).
Fields of papers citing papers by Jingyan Wei
This network shows the impact of papers produced by Jingyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Wei. The network helps show where Jingyan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingyan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy Hit paper breakdown → | 2013 | 1510 |
| 2 | Field-Free Isolation of Exosomes from Extracellular Vesicles by Microfluidic Viscoelastic Flows Hit paper breakdown → | 2017 | 421 |
| 3 | 2010 | 415 | |
| 4 | 2014 | 217 | |
| 5 | 2019 | 203 | |
| 6 | 2017 | 154 | |
| 7 | 2021 | 133 | |
| 8 | 2017 | 80 | |
| 9 | 2003 | 68 | |
| 10 | 2003 | 53 | |
| 11 | 2017 | 49 | |
| 12 | 2009 | 39 | |
| 13 | 2018 | 38 | |
| 14 | 2022 | 35 | |
| 15 | 2017 | 25 | |
| 16 | 2007 | 25 | |
| 17 | 2014 | 23 | |
| 18 | 2017 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2016 | 17 |
About Jingyan Wei
Jingyan Wei is a scholar working on Molecular Biology, Nutrition and Dietetics, Toxicology, Oncology and Biomedical Engineering, having authored 55 papers that have together received 3.8k indexed citations. Recurring topics across this work include Selenium in Biological Systems (17 papers), Redox biology and oxidative stress (12 papers), Organoselenium and organotellurium chemistry (9 papers), Inflammatory mediators and NSAID effects (5 papers), Extracellular vesicles in disease (5 papers), Glutathione Transferases and Polymorphisms (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Biomaterials (506 citations), Molecular Biology (2.5k citations), Biomedical Engineering (1.3k citations) and Immunology (288 citations). Jingyan Wei has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guangjun Nie, Gregory J. Anderson, Suping Li, Tianjiao Ji, Jian Song, Yanhua Tian, Motao Zhu, Yuliang Zhao, Xiaochun Wu and Yinlong Zhang. Their work appears in journals such as IUBMB Life, Free Radical Biology and Medicine, Nano Letters, Biomaterials and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.